Bionyra brings in $165M for next-generation immune drugs

Monday, June 22, 2026Gwendolyn WuView original

The biotech, co-founded by Sofinnova Partners and a former Sanofi immunology R&D head, is testing new biologics against common immune conditions.

Read the full article on the original site.